Can-Fire Biopharma Ltd., of Petach Tikva, Israel, was granted Japanese Patent No. 5467872, “Process for the Synthesis of IB-MECA.” The patent covers a method for the chemical synthesis of the A3 adenosine receptor agonist, IB-MECA, the active pharmaceuticals ingredient.
Outside of the US
In the U.S. and Canada: +1-800-336-4474
Outside the U.S.: +44-203-684-1796
Hours: Monday - Friday, 8:00am - 6:00 pm EST